Navigation Links
FDA Stem Cell Approval Breakthrough Laudable
Date:1/23/2009

SAN CLEMENTE, Calif., Jan. 23 /PRNewswire/ -- Today the FDA announced approval for the first clinical trials on humans using Embryonic Stem Cells but Adult Stem Cell scientist Christian Drapeau says the experts may not be telling the whole story; Adult Stem Cells have greater potential with less risk.

"While the FDA approval is an exciting step forward toward freeing science from the shackles of politics," said Drapeau. "The expert commentary we're seeing surrounding the FDA's action is misleading."

Christian Drapeau, an early advocate of ASC science, posits that ACS are showing the greatest potential for scientific and medical advances.

Drapeau says that ASC can be a safer alternative to Embryonic Stem Cells because of a lower risk of tumor formation while studies show ASC to have comparable potential or even more in repairing damaged tissues or organs. This contradicts experts on morning talk shows who cast doubt on the efficacy of ACS research.

"The use of ASC requires a different thinking, but they can be as effective as ESC, if not more. ASC do not grow easily in vitro and they are not easy to re-program. But there are ways of using ASC that can be just as effective as methods using ESC, without the risk of tumor formation."

"Adult Stem Cells are showing great promise," notes Drapeau. "This is a very very important area of research right now and people must realize that Embryonic Stem Cells are not the only Stem Cell phenomenon out there."

"The scientific community is rejoicing today as a new age of medicine is ushered in concurrent with the Obama administration but the possibilities of Adult Stem Cell science are so mind boggling in terms of healing physical damage and the elimination of disease that the scientific community must focus on what works best, with the least amount of risk and the greatest scope of application," said Drapeau.

Media Contact: Maggie Jessup 360.521.0437 or maggie@platformstrategy.com

Christian Drapeau: America's best known advocate for Adult Stem Cell research and the medical applications of Adult Stem Cells. His theory that Adult Stem Cells are nothing less than the body's natural healing system has profound implications for every area of modern medicine. He holds a Masters degree in neurophysiology from the Department of Neurology and Neurosurgery at Montreal's McGill University. http://www.christiandrapeau.com


'/>"/>
SOURCE Christian Drapeau
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Reclast(R) Receives US FDA Approval as First and Only Once-Yearly Treatment for Women With Postmenopausal Osteoporosis
2. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
3. CryoCor Receives FDA Approval for Right Atrial Flutter
4. Ranbaxy Receives Approval to Manufacture and Market Hydrocodone Bitartrate and Acetaminophen Tablets USP
5. InterMune Announces Approval of Clinical Trial Authorization for Phase 1b Trial of ITMN-191
6. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
7. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
8. Taxotere(R) (docetaxel) Granted FDA Approval to Treat Locally Advanced Head and Neck Cancer Prior to Chemoradiotherapy and Surgery
9. Survival Data in FDA Approval for ERBITUX(R) (Cetuximab) Supports use as a Single Agent in Patients with Advanced Colorectal Cancer
10. Aptivus(R) (tipranavir) Capsules Granted Full Approval by the U.S. FDA
11. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/22/2017)... FALLS, N.J. , March 22, 2017  CANTEL MEDICAL ... Jorgen B. Hansen , President and CEO, will be presenting ... Conference at the Westin Grand Central Hotel in ... Wednesday, April 5, 2017 at 3:00 p.m. ET. In addition, ... day. A live audio webcast will be ...
(Date:3/22/2017)... JACKSONVILLE, Fla. , March 22, 2017 /PRNewswire/ ... clinical-stage immuno-oncology company specializing in the development of ... of cancer and metastatic disease, today announced that ... Industry conferences. Dr. Glynn Wilson ... an overview of the company,s business, clinical pipeline ...
(Date:3/22/2017)... 22, 2017 Hologic, Inc. (Nasdaq: ... acquisition of Cynosure, Inc., a leader in medical aesthetics ... "We are pleased to complete our acquisition ... Michael Davin and the entire Cynosure team to ... medical aesthetics market," said Steve MacMillan , Hologic,s ...
Breaking Medicine Technology:
(Date:3/22/2017)... ... March 22, 2017 , ... Sam & Associates Insurance Agency, ... and related services to residents of the region, is embarking on a charity ... and wild lands. , Endangered Species International is committed to ending the anthropogenic ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... California and Nevada and LABS, Inc., announced the future opening of a CLIA ... screening and serology testing used to determine the suitability of potential organ ...
(Date:3/22/2017)... FL (PRWEB) , ... March 22, 2017 , ... An ... mosquitoes could occasionally transmit HIV, reports Leslie Norins, MD, PhD. He says ... cases of domestically transmitted Zika virus and in new infections with HIV. ...
(Date:3/22/2017)... ... March 22, 2017 , ... Intrinsic Imaging, ... therapeutic experience and operational excellence in oncology clinical trials, proudly announces today that ... treatment of non-small cell lung cancer and small cell lung cancer. , Throughout ...
(Date:3/22/2017)... Oklahoma City, OK (PRWEB) , ... March 22, ... ... firm offering insurance and financial planning services to regional families and business owners, ... provide meaningful support to young people in the area. , A growing number ...
Breaking Medicine News(10 mins):